Delivery Order SPE2DR25D1100-SPE2DR26FCK6B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,535.99 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packages) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- The Defense Logistics Agency awarded a $2,179.40 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100. This firm fixed price, competitively awarded contract with no set-aside designation is scheduled for completion by July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $3,606.82 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. The contract employs firm fixed pricing and is not set aside, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,331.08 for Ambien CR 6.25 mg tablets (100-count units) on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The pharmaceutical distributor will perform the delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $3,829.57 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on October 17, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $2,148.62 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count). The contract employs firm fixed-price pricing with no set-aside designation, indicating a competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,116.22 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a child contract under the company's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $2,358.09 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ambien CR 12.5 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by August 14, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,167.17 to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with a firm fixed price and an ultimate completion date of September 9, 2025. This competitively awarded, non-set-aside contract was issued on September 8, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCK6BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,559.10 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical and medical supply deliveries to the Defense Logistics Agency and Defense Health Agency. The company's federal contract awards demonstrate capability across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies supporting military healthcare systems worldwide. This particular delivery order for sedative medication reflects the company's role in supplying essential pharmaceutical products to support military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/24/25 |